Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A screening program for anti-DR typing reagents.

P Vassalli, M Jeannet, P de Moerloose

    Tissue Antigens
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?

    Journal of thrombosis and haemostasis : JTH·2012
    Same author

    [Thrombophilia: which tests in 2012?].

    La Revue de medecine interne·2012
    Same author

    Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.

    Journal of internal medicine·2012
    Same author

    Recommendations for assessment, monitoring and follow-up of patients with haemophilia.

    Haemophilia : the official journal of the World Federation of Hemophilia·2011
    Same author

    Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations.

    Haemophilia : the official journal of the World Federation of Hemophilia·2011
    Same author

    Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study.

    Journal of thrombosis and haemostasis : JTH·2010

    This study screened 694 sera to find specific reagents for human leukocyte antigen (HLA)--DR typing. The efficient method identified 25 sera specific for well-defined DR antigens, aiding in HLA--DR typing.

    Area of Science:

    • Immunogenetics
    • Serology

    Background:

    • Screening of 694 sera for human leukocyte antigen (HLA)--DR typing reagents.
    • Initial testing on B and T cells, followed by platelet absorption for B-cell reactive sera.
    • Aims to identify monospecific reagents for accurate HLA--DR typing.

    Discussion:

    • The implemented procedure efficiently reduced platelet usage.
    • Observed reduced B-cell reactivity when HLA--A, --B, --C antibodies were absent.
    • Highlights the effectiveness of the screening strategy.

    Key Insights:

    • Identified 150 sera with anti-B cell antibodies.
    • Successfully identified 25 sera specific for well-defined DR antigens.
    • The method proved reasonably efficient for identifying HLA--DR typing reagents.

    Related Experiment Videos

    Outlook:

    • Potential for improved HLA--DR typing strategies.
    • Further validation of identified monospecific reagents.
    • Contribution to understanding HLA--DR antigen specificity.